STD Testing Devices Market The Increasing Cases of Sexually Transmitted Diseases, coupled with the Rising Geriatric Population is Projected to Boost Market Growth at a Healthy CAGR of 9.3% During the Forecast Period of 2019 to 2025 :

Pune, India, November 2019, MRFR Press Release/- Market Research Future has published a Half-Cooked Research Report on the Global STD Testing Devices Market.

Market Highlights

According to MRFR analysis, STD Testing Devices Market is expected to register a CAGR of 9.3% during the forecast period of 2019 to 2025 and accounted for USD 70.29 Billion in 2018.

The growth of the global STD testing devices market is driven by various factors such as an increase in the prevalence of sexually transmitted diseases, increasing prevalence of lifestyle diseases, and increasing mergers & acquisitions by prominent players in the market. However, lack of knowledge about the symptoms is projected to hamper the growth of the global STD testing devices market.

The Global STD Testing Devices Market is currently dominated by several market players. Additionally, growing initiatives to create awareness is driving the growth of the market. For instance, Inovio Pharmaceuticals, Inc. in 2018, signed an agreement with ApolloBio Corp. for the exclusive rights for the development, manufacturing, and commercialization of VGX – 3100, Inovio’s DNA immunotherapy product. This product is used for pre-cancer indication.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the rising per capita healthcare expenditure. The STD testing devices market in the Americas has further been branched into North America and Latin America, with the North American market is divided into the US and Canada. The European STD testing devices market has been categorized into Western Europe and Eastern Europe. The Western European market has further been classified into Germany, France, UK, Italy, Spain, and the rest of Western Europe. The STD testing devices market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing prevalence of sexually transmitted diseases and increasing patient pool, the market in Asia-Pacific is expected to be the fastest-growing. The STD testing devices market in the Middle East & Africa has been bifurcated into the Middle East and Africa.


The Global STD Testing Devices Market has been segmented based on type and end-user.

The market, based on type, has been divided into laboratory devices and point of care (POC) devices. The laboratory devices segment is expected to be the largest. The laboratory devices are further segmented into thermal cyclers, cellulose-based devices, flow cytometers, enzyme-linked immunosorbent assay (ELISA) and others. The point of care devices is segmented into phone chips, rapid diagnostic kits, and others.

In terms of end-user, the global STD testing devices market has been segmented into hospitals and clinics diagnostic laboratories and research laboratories and institutes. Hospitals and clinics take up the largest share. The hospital's segment is expected to hold the largest share of the market, as these are the primary locations where patients receive treatment.

Browse Full Report Details @

Key Players

Some of the Key Players in the Global STD Testing Devices Market are Abbott (US), Meridian Bioscience (US), Thermo Fisher Scientific (US), MedMira Inc. (Canada), F. Hoffmann-La Roche AG (Switzerland), Bio-Rad Laboratories, Inc. (US), Diasorin S.p.A (Italy), Becton Dickinson and Company (US), Hologic, Inc. (US), Cepheid (Danaher Corporation) (US), bioMeriuex (France), Qaigen Inc. (US), OraSure Technologies (US), GenePOC Inc. (Canada).